Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients

被引:17
作者
Chen, Hung-Yuan [1 ,2 ,3 ]
Kao, Tze-Wah [1 ,2 ]
Huang, Jenq-Wen [1 ,2 ]
Chu, Tzong-Shinn [1 ,2 ]
Wu, Kwan-Dun [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[3] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan
关键词
insulin resistance; metabolic syndrome; renal function; residual; peritoneal clearance; solute transport;
D O I
10.1159/000113506
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Metabolic syndrome (MetS) and insulin resistance (IR) strongly promote macrovascular complications and endothelial dysfunction. They accelerate the progression of renal dysfunction in chronic kidney disease patients. However, their correlation with residual renal function (RRF) and peritoneal characteristics have never been investigated. Methods: The inter-relationships of IR (homeostatic model assessment, HOMA(IR)), serum adiponectin level, body mass index (BMI), highly sensitive C-reactive protein (hs-CRP), RRF, peritoneal solute clearance (Kt/V-urea) and solute transport rate of 104 chronic peritoneal dialysis (PD) patients were examined. Results: Patients with (n = 57) and without (n = 47) clinically diagnosed MetS had the same degree of RRF, peritoneal Kt/V-urea, and solute transport rate. Higher HOMA(IR) (p = 0.011), BMI (p = 0.01) and hs-CRP (p = 0.032), as well as lower adiponectin (p = 0.019), were associated with lower peritoneal Kt/V-urea. Serum adiponectin was negatively associated with solute transport rate (p = 0.02). In multiple regression analysis, higher HOMA(IR) (p = 0.005), BMI (p = 0.021) and hs-CRP (p < 0.001) correlated with lower peritoneal Kt/V-urea. Conclusions: MetS plays an important role in both macrovascular complications and endothelial dysfunction in chronic PD patients, which correlates with changes in peritoneal solute clearance and solute transport rate but not RRF. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 27 条
[1]   Residual renal function: Considerations on its importance and preservation in dialysis patients [J].
Chandna, SM ;
Farrington, K .
SEMINARS IN DIALYSIS, 2004, 17 (03) :196-201
[2]   Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis [J].
Chung, SH ;
Heimbürger, O ;
Stenvinkel, P ;
Bergström, J ;
Lindholm, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) :2240-2245
[3]  
Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285
[4]   What really happens to people on long-term peritoneal dialysis? [J].
Davies, SJ ;
Phillips, L ;
Griffiths, AM ;
Russell, LH ;
Naish, PF ;
Russell, GI .
KIDNEY INTERNATIONAL, 1998, 54 (06) :2207-2217
[5]  
Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046
[6]   Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty rats [J].
Desouza, CV ;
Gerety, M ;
Hamel, FG .
ATHEROSCLEROSIS, 2006, 184 (02) :283-289
[7]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[8]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[9]  
Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211
[10]   Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function [J].
Huang, JW ;
Yen, CJ ;
Chiang, HW ;
Hung, KY ;
Tsai, TJ ;
Wu, KD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (06) :1047-1055